array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2495) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(108) "The police found twenty truck doors: Now two men have been arrested in the case of special thefts TV MIDWEST" ["snippet_en"]=> string(49) "Citizen inquiries helped the police on their way." ["url"]=> string(115) "https://www.tvmidtvest.dk/holstebro/politiet-fandt-tyve-lastbildoere-nu-er-to-maend-anholdt-i-sagen-om-saertyverier" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d6eea2b8-5665-47d4-bcbd-6ca7b1a76e49" ["source"]=> string(13) "tvmidtvest.dk" ["publication_date"]=> string(10) "2024-03-31" ["categories"]=> array(1) { [0]=> string(5) "Legal" } } [1]=> array(7) { ["title_en"]=> string(42) "4 Gamblers in Lamandau Prepare to Be Tried" ["snippet_en"]=> string(174) "The arrest of the suspects, said Kasat, began with a public report that there was gambling activity at a shop on Jalan Maskaya Influence, Nanga Bulik Village, Bulik District." ["url"]=> string(80) "https://www.borneonews.co.id/berita/333976-4-penjudi-di-lamandau-bersiap-diadili" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c4015942-7a3e-442e-9a4f-ffc2d86217f9" ["source"]=> string(16) "borneonews.co.id" ["publication_date"]=> string(10) "2024-03-18" ["categories"]=> array(1) { [0]=> string(5) "Legal" } } [2]=> array(7) { ["title_en"]=> string(54) "Official Govt & Legal Notices For Jan 8 2024 - Bernews" ["snippet_en"]=> string(295) "The official Government and Legal notices for today [Jan 8] include board appointments, contracts and notice of intended marriage. Board Appointments Bermuda Monetary Authority Notice type Government Notice Notice sub type Boards Appointments Notice ID GN0019/2024 Public Authorities/ Department" ["url"]=> string(67) "https://bernews.com/2024/01/official-govt-legal-notices-jan-8-2024/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3357ff7b-7673-4a48-8d57-e0f5df7ff597" ["source"]=> string(11) "bernews.com" ["publication_date"]=> string(10) "2024-01-08" ["categories"]=> array(1) { [0]=> string(5) "Legal" } } [3]=> array(7) { ["title_en"]=> string(107) "Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB" ["snippet_en"]=> string(270) "31.12.2023 - Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of RayzeBio, Inc. (NasdaqGM: RYZB) to Bristol-Myers Squibb Company (NYSE: BMY). Under the terms of ..." ["url"]=> string(217) "https://www.wallstreet-online.de/nachricht/17667816-rayzebio-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-proposed-sale-of-rayzebio-inc-ryzb" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e472c118-19dd-4bb8-af00-394b567cf29e" ["source"]=> string(20) "wallstreet-online.de" ["publication_date"]=> string(10) "2023-12-31" ["categories"]=> array(2) { [0]=> string(46) "Management of Legal and Regulatory Environment" [1]=> string(5) "Legal" } } [4]=> array(7) { ["title_en"]=> string(99) "Double Hard Blow for Bayer: Stock Market Collapse and Crushing Legal Loss on Roundup! - PLANETES360" ["snippet_en"]=> string(153) "Bayer shares in Germany suffered their biggest intraday fall in history, losing as much as 21% to reach levels not seen since the Great Financial Crisis." ["url"]=> string(117) "https://planetes360.fr/double-coup-dur-pour-bayer-effondrement-boursier-et-perte-judiciaire-ecrasante-sur-le-roundup/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/28c6b21f-1309-44b5-a7d7-788b08496a51" ["source"]=> string(14) "planetes360.fr" ["publication_date"]=> string(10) "2023-11-20" ["categories"]=> array(8) { [0]=> string(15) "Market Movement" [1]=> string(10) "Insolvency" [2]=> string(7) "Economy" [3]=> string(12) "Stock Market" [4]=> string(18) "Financial Distress" [5]=> string(6) "Crisis" [6]=> string(24) "Systemic Risk Management" [7]=> string(5) "Legal" } } [5]=> array(7) { ["title_en"]=> string(90) "Karyopharm Enters Clinical Trial Collaboration, Supply Agreement With Bristol-Myers Squibb" ["snippet_en"]=> string(280) "(RTTNews) - Karyopharm Therapeutics Inc. (KPTI) has entered into a clinical trial collaboration and supply agreement with Bristol-Myers Squibb (BMY) to evaluate the investigational cereblon E3 ligase modulator agent mezigdomide in combination with Karyopharm's selinexor, an appro" ["url"]=> string(121) "https://www.nasdaq.com/articles/karyopharm-enters-clinical-trial-collaboration-supply-agreement-with-bristol-myers-squibb" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-10-30" ["categories"]=> array(4) { [0]=> string(13) "Collaboration" [1]=> string(15) "Deals & Tenders" [2]=> string(23) "Supply Chain Management" [3]=> string(5) "Legal" } } [6]=> array(7) { ["title_en"]=> string(55) "Abilify Drugmaker Reaches $19.5M Settlement With States" ["snippet_en"]=> string(174) "Bristol-Myers Squibb reached a $19.5 million settlement Thursday on its off-label promotion of Abilify, an anti-psychotic that was originally designed to treat schizophrenia." ["url"]=> string(86) "https://www.courthousenews.com/abilify-drugmaker-reaches-19-5m-settlement-with-states/" ["image_url"]=> NULL ["source"]=> string(18) "courthousenews.com" ["publication_date"]=> string(10) "2023-10-15" ["categories"]=> array(2) { [0]=> string(16) "Case Settlements" [1]=> string(5) "Legal" } } [7]=> array(7) { ["title_en"]=> string(73) "Grünenthal and Freshfields win injunction against Teva testosterone drug" ["snippet_en"]=> string(301) "In the Netherlands, German pharmaceutical company Grünenthal has been successful in preliminary relief proceedings against Teva over long-acting testosterone drug Nebido (case ID: C/09/653142). The medicine’ s active substance is testosterone undecanoate, which doctors prescribe to treat long-term" ["url"]=> string(107) "https://www.juve-patent.com/cases/grunenthal-and-freshfields-win-injunction-against-teva-testosterone-drug/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/20dbcabd-c36e-4700-adec-850cb01e97a4" ["source"]=> string(15) "juve-patent.com" ["publication_date"]=> string(10) "2023-10-09" ["categories"]=> array(3) { [0]=> string(11) "Acquisition" [1]=> string(21) "Intellectual Property" [2]=> string(5) "Legal" } } [8]=> array(7) { ["title_en"]=> string(63) "Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now." ["snippet_en"]=> string(124) "These three healthcare stocks to sell are waving red flags at investors who should pay attention or suffer the consequences." ["url"]=> string(96) "https://investorplace.com/2023/09/beware-3-healthcare-stocks-waving-massive-red-flags-right-now/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/063ac834-700c-4588-b0a2-9a3ae7b154e9" ["source"]=> string(17) "investorplace.com" ["publication_date"]=> string(10) "2023-09-24" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(5) "Legal" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(76) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company